Page 4 - Eric Leire News Today

Genflow have announced a scientific research collaboration with RoAR to study the ageing process in liver tissue.

Investegate announcements from Genflow Biosciences, New Research Collaboration

Investegate announcements from Genflow Biosciences, Non-Dilutive Grant Research Award

Genflows focus is on the Sirtuin 6 gene, or SIRT6 for short, which is seen as the master regulator of healthy ageing.

Genflows focus is on the Sirtuin 6 gene, or SIRT6 for short, which is seen as the master regulator of healthy ageing.

Eric Leire (CEO) Genflow Biosciences PLC (LSE:GENF) (Genflow Biosciences PLC (LSE:GENF)) Presenting at the proactive One2One Virtual Forum - 20th January...

Jim Mellon-backed Genflow set to become first company in its field to make European market debut

Genflow’s solution sets out to target four out of the nine hallmarks directly, and two others indirectly.

Dr Eric Leire, MD, MBA, is a former researcher at Harvard, Pfizer, Schering Plough and Pharmacia. He is CEO of Genflow Biosciences, a UK-based biotech company delivering therapeutics that potentially halt or slow the ageing process.